Page last updated: 2024-09-04

docetaxel anhydrous and Anemia, Hemolytic

docetaxel anhydrous has been researched along with Anemia, Hemolytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abebe, L; Bhagwati, N; Jain, D; Marcoullis, G; Talusan, R; Wiernik, PH	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Anemia, Hemolytic

Article	Year
Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case report. Medical oncology (Northwood, London, England), 2002, Volume: 19, Issue:3 Topics: Adenocarcinoma; Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Docetaxel; Female; Hemolysis; Humans; Methylprednisolone; Middle Aged; Paclitaxel; Plasmapheresis; Taxoids	2002

Article

Year

Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case report.

Medical oncology (Northwood, London, England), 2002, Volume: 19, Issue:3

Topics: Adenocarcinoma; Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Docetaxel; Female; Hemolysis; Humans; Methylprednisolone; Middle Aged; Paclitaxel; Plasmapheresis; Taxoids

2002